Clinical outcomesa
| Major Complication | Statin Use | No Statin Use | P Value |
|---|---|---|---|
| Major ipsilateral ischemic stroke | 4.9% (11/226) | 3.4% (29/865) | .319 |
| Major ipsilateral intracranial hemorrhage | 0.9% (2/226) | 2.3% (20/865) | .284 |
| Major morbidity | 5.8% (13/226) | 5.7% (49/865) | 1.000 |
| Neurologic mortality | 3.5% (8/226) | 3.2% (28/865) | .835 |
| Major morbidity and neurologic mortality | 7.5% (17/226) | 7.1% (61/865) | .773 |
| All-cause mortality | 4.4% (10/226) | 3.9% (34/865) | .706 |
↵a Analysis was performed with the Pearson χ2 test.